Sunshine Biopharma Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Sunshine Biopharma Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Sunshine Biopharma Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 2M shares, a 92.2% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 2M -23.7M -92.2% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 1.17M -24.6M -95.5% Jun 30, 2024 10-Q/A 2024-08-20
Q1 2024 995K -21.1M -95.5% Mar 31, 2024 10-Q 2024-05-20
Q4 2023 14K* -22.6M Dec 31, 2023 10-Q 2024-11-05
Q3 2023 25.7M +6.79M +36% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 25.7M +6.86M +36.3% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 22.1M +15M +210% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 22.6M +20M +772% Dec 31, 2022 10-K 2024-03-28
Q3 2022 18.9M -491M -96.3% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 18.9M -467M -96.1% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 7.15M -458M -98.5% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 2.59M +859K +49.6% Dec 31, 2021 10-K 2023-04-04
Q3 2021 510M +206M +67.6% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 486M +216M +80.2% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 465M +405M +679% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 1.73M -33.6M -95.1% Dec 31, 2020 10-K 2022-03-21
Q3 2020 304M -7.01M -2.25% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 270M +166M +159% Jun 30, 2020 10-Q/A 2020-08-31
Q1 2020 59.7M -29.7M -33.2% Mar 31, 2020 10-Q 2020-05-18
Q4 2019 35.3M +31M +725% Dec 31, 2019 10-K 2021-03-30
Q3 2019 311M -1.27B -80.4% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 104M -1B -90.6% Jun 30, 2019 10-Q 2019-08-15
Q1 2019 89.3M -860M -90.6% Mar 31, 2019 10-Q 2019-05-20
Q4 2018 4.28M -41.7M -90.7% Dec 31, 2018 10-K 2020-05-01
Q3 2018 1.59B +667M +72.6% Sep 30, 2018 10-Q 2018-11-16
Q2 2018 1.1B +236M +27.1% Jun 30, 2018 10-Q 2018-08-17
Q1 2018 949M +131M +16% Mar 31, 2018 10-Q 2018-05-22
Q4 2017 45.9M -723M -94% Dec 31, 2017 10-K 2019-04-12
Q3 2017 919M +283M +44.5% Sep 30, 2017 10-Q 2017-11-15
Q2 2017 869M +594M +217% Jun 30, 2017 10-Q 2017-08-11
Q1 2017 818M +585M +251% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 769M +571M +288% Dec 31, 2016 10-K 2018-04-02
Q3 2016 636M +502M +373% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 274M +148M +117% Jun 30, 2016 10-Q 2016-08-16
Q1 2016 233M +130M +127% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 198M +125M +170% Dec 31, 2015 10-K 2017-04-17
Q3 2015 134M +65.5M +95% Sep 30, 2015 10-Q 2015-11-04
Q2 2015 126M +60.5M +91.7% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 102M +39.8M +63.5% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 73.6M +13.3M +22% Dec 31, 2014 10-K 2016-03-25
Q3 2014 68.9M +12.1M +21.2% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 66M +9.53M +16.9% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 62.7M +6.49M +11.5% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 60.3M +8.88M +17.3% Dec 31, 2013 10-K 2015-03-11
Q3 2013 56.8M +5.45M +10.6% Sep 30, 2013 10-Q 2013-11-04
Q2 2013 56.4M +7.23M +14.7% Jun 30, 2013 10-Q 2013-08-06
Q1 2013 56.2M +7.46M +15.3% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 51.4M +2.69M +5.52% Dec 31, 2012 10-K 2014-03-19
Q3 2012 51.4M +20.4M +65.6% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 49.2M +18.5M +60.2% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 48.7M +18M +58.7% Mar 31, 2012 10-Q 2012-05-08
Q4 2011 48.7M +18M +58.8% Dec 31, 2011 10-K 2013-03-15
Q3 2011 31M Sep 30, 2011 10-Q 2011-11-08
Q2 2011 30.7M Jun 30, 2011 10-Q 2011-08-09
Q1 2011 30.7M Mar 31, 2011 10-Q 2011-05-12
Q4 2010 30.7M Dec 31, 2010 10-K 2012-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.